Evolución de sunitinib en 1ª línea en CCRm: Esquemas alternativos - page 20

Estudio RAINBOW:

Diseño

Sunitinib 50 mg/d

n=208

Sunitinib 50mg/d

CCRm

24 Centros Italia

(Esquema 4/2

)

(Esquema 2/1)

N=249

n=41

Sunitinib 50 mg/d

(Esquema 2/1)

Sunitinib 50 mg/d

Grupo control n=211

(Esquema 4/2

)

Bracarda S et al, Ann Oncol. 2015

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,10,11,12,13,14,15,16,17,18,19 21,22,23,24,25,26,27,28,29,30,...43